Adient (ADNT)
(Delayed Data from NYSE)
$19.74 USD
+0.02 (0.10%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $19.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.74 USD
+0.02 (0.10%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $19.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Zacks News
Allison Transmission (ALSN) Down 8.5% Since Q4 Earnings Miss
by Zacks Equity Research
Allison Transmission (ALSN) projects net sales for 2021 in the range of $2,265-$2,415 million, indicating an increase from $2,081 million recorded in 2020.
What's in the Offing for Hyliion (HYLN) This Earnings Season?
by Zacks Equity Research
Positive impact of Hyliion's (HYLN) combination with Tortoise Acquisition and use of latest technology are likely to have fueled the company's Q4 performance.
Is a Beat in Store for Magna (MGA) This Earnings Season?
by Zacks Equity Research
Robust growth in Body Exteriors & Structures, Power Vision and Complete Vehicles segments during the October-December period likely to reflect on Magna's (MGA) Q4 results.
5 Low Price-to-Book Stocks for Value Investors
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
American Axle (AXL) Q4 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
American Axle (AXL) projects full-year 2021 revenues of $5.3-$5.5 billion and adjusted EBITDA of $850-$925 million.
Are Investors Undervaluing Adient (ADNT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Adient (ADNT) Q1 Earnings Beat, Sales Fall Shy of Estimates
by Zacks Equity Research
Adient (ADNT) surpasses fiscal first-quarter 2021 earnings mark on higher-than-anticipated EBITDA across each of the segments.
Ride Market Rally With High-Beta ETFs & Stocks
by Sweta Killa
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
Lear (LEA) Q4 Earnings and Sales Trump Estimates, Up Y/Y
by Zacks Equity Research
Lear (LEA) envisions full-year 2021 net sales between $19.8 billion and $20.8 billion.
Adient (ADNT) Beats Q1 Earnings Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 80.00% and -1.78%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Cummins' (CMI) Q4 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cummins projects full year 2021 revenues to be up 8-12% and EBITDA to be in the range of 15-15.5% of sales.
Meritor (MTOR) Beats on Q1 Earnings & Sales, Raises FY21 View
by Zacks Equity Research
Meritor (MTOR) projects sales in the range of $3.65-$3.8 billion for fiscal 2021, up from the prior estimate of $3.1-$3.35 billion.
New Strong Buy Stocks for February 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Gentex (GNTX) Q4 Earnings Beat, '21 Sales Outlook Upbeat
by Zacks Equity Research
Gentex (GNTX) envisions net sales in the band of $1.94-2.02 billion for 2021, indicating an increase from 2020 revenues of $1.68 billion.
5 Promising Price-to-Book Value Stocks to Buy Now
by Kinjel Shah
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
ADNT vs. SHYF: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ADNT vs. SHYF: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Alexion Pharmaceuticals, Adient, Affiliated Managers Group and General Motors
by Zacks Equity Research
Zacks.com featured highlights include: Alexion Pharmaceuticals, Adient, Affiliated Managers Group and General Motors
4 Promising Price-to-Book Value Stocks to Buy Now
by Kinjel Shah
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Adient (ADNT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Adient (ADNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Why Is Adient (ADNT) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Adient (ADNT) Stock Might be a Great Pick
by Zacks Equity Research
Adient (ADNT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
4 Auto Stocks Poised to Continue Their Winning Streaks in 2021
by Pooja Dhona
The auto sector is projected to witness year-on-year earnings growth of 58% in 2021. Amid the upbeat scenario, stocks like TSLA, MGA, CMI and ADNT are set to fly high next year.
The Zacks Analyst Blog Highlights: RYAM, CVGI, Apergy, Adient and Michaels
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RYAM, CVGI, Apergy, Adient and Michaels
What Makes Adient (ADNT) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Adient (ADNT) have what it takes to be a top stock pick for momentum investors? Let's find out.